A first: All respond to gene therapy in blood cancer study

CHICAGO – Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small – 35 people – every patient responded and all but two were in some level of remission within two months.

Sign up to continue

Print subscriber?     Sign up for Full Access!

Please sign up for as low as 36 cents per day to continue viewing our website.

Digital subscribers receive

  • Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone.
  • Access nashuatelegraph.com, view our digital edition or use our Full Access apps.
  • Get more information at nashuatelegraph.com/fullaccess

Sign up or Login

COMMENTS